Edgewise Therapeutics (EWTX) Capital Expenditures (2020 - 2026)
Edgewise Therapeutics (EWTX) posted Capital Expenditures of $32,000 for Q2 2026, down 36.0% from $50,000 a year earlier and down 87.7% from the prior quarter.
Edgewise Therapeutics (EWTX) Capital Expenditures (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Edgewise Therapeutics was $454,000, down 48.9% year-over-year; for FY2025, it was $256,000, down 80.5% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- In prior years, Edgewise Therapeutics' Capital Expenditures was $1.31 million in FY2024 (-77.2%), $5.75 million in FY2023 (+3.6%), $5.55 million in FY2022 (+730.2%) and $668,000 in FY2021 (+229.1%).
- The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q3 2020.
- On a year-over-year basis, Capital Expenditures increased in three of the last eight quarters, with growth averaging 27.5%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2022, with growth of 628.9%; the weakest was Q4 2023, with a decline of 95.1%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $260,000 (Q1 2026), $73,000 (Q4 2025) and $89,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Edgewise Therapeutics | 5.00 Bn | 2.24 Bn | - | 17,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 17,000.00 |
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 260,000.00 |
| Dec 31, 2025 | 73,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | 520,000.00 |
| Jun 30, 2024 | 221,000.00 |
| Mar 31, 2024 | 297,000.00 |
| Dec 31, 2023 | 161,000.00 |
| Sep 30, 2023 | 457,000.00 |
| Jun 30, 2023 | 759,000.00 |
| Mar 31, 2023 | 4.37 Mn |
| Dec 31, 2022 | 3.29 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 554,000.00 |
| Mar 31, 2022 | 369,000.00 |
| Dec 31, 2021 | 79,000.00 |
Edgewise Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EWTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EWTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EWTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();